Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark A Simmons

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|August 19, 2006
Functional selectivity of NK1 receptor signaling: peptide agonists can preferentially produce receptor activation or desensitizationMark A Simmons
Molecular Interventions|July 5, 2005
Functional selectivity, ligand-directed trafficking, conformation-specific agonism: what's in a name?Mark A Simmons
Bioorganic & Medicinal Chemistry Letters|November 8, 2011
3D-Quantitative structure-activity relationship and docking studies of the tachykinin NK3 receptorWerner J Geldenhuys, Mark A Simmons
BMC Chemical Biology|June 22, 2001
Analysis of fluorescently labeled substance P analogs: binding, imaging and receptor activationVicki J Bennett, Mark A Simmons
Journal of Medicinal Chemistry|November 5, 2010
Virtual screening to identify novel antagonists for the G protein-coupled NK3 receptorWerner J Geldenhuys, Stephanie R Kuzenko, Mark A Simmons
Pharmacology, Biochemistry, and Behavior|October 21, 2009
Acute nicotine and phencyclidine increase locomotor activity of the guinea pig with attenuated potencies relative to their effects on rat or mouseMark A Simmons, Jennifer L Werkheiser, Thomas J Hudzik
Brain, Behavior, and Immunity|August 21, 2012
Repeated stressor exposure regionally enhances beta-adrenergic receptor-mediated brain IL-1β productionVeronica M Porterfield, Kristin M Gabella, Mark A Simmons, et al.
Pharmacology Research & Perspectives|October 10, 2022
American Society for Pharmacology and Experimental Therapeutics Division for Pharmacology Education at EB2022-Meeting reportJoe B Blumer, Marieke Kruidering, Katharina Brandl, et al.
European Journal of Pharmacology|July 19, 2008
The role of the N-terminal and mid-region residues of substance P in regulating functional selectivity at the tachykinin NK1 receptorShane A Perrine, Debbie J Beard, John K Young, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|June 5, 2012
The adenosine 2A receptor agonist GW328267C improves lung function after acute lung injury in ratsHans G Folkesson, Stephanie R Kuzenko, David A Lipson, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
The Journal of Pharmacology and Experimental Therapeutics|August 19, 2006
Functional selectivity of NK1 receptor signaling: peptide agonists can preferentially produce receptor activation or desensitizationMark A Simmons
Molecular Interventions|July 5, 2005
Functional selectivity, ligand-directed trafficking, conformation-specific agonism: what's in a name?Mark A Simmons
Bioorganic & Medicinal Chemistry Letters|November 8, 2011
3D-Quantitative structure-activity relationship and docking studies of the tachykinin NK3 receptorWerner J Geldenhuys, Mark A Simmons
BMC Chemical Biology|June 22, 2001
Analysis of fluorescently labeled substance P analogs: binding, imaging and receptor activationVicki J Bennett, Mark A Simmons
Journal of Medicinal Chemistry|November 5, 2010
Virtual screening to identify novel antagonists for the G protein-coupled NK3 receptorWerner J Geldenhuys, Stephanie R Kuzenko, Mark A Simmons
Pharmacology, Biochemistry, and Behavior|October 21, 2009
Acute nicotine and phencyclidine increase locomotor activity of the guinea pig with attenuated potencies relative to their effects on rat or mouseMark A Simmons, Jennifer L Werkheiser, Thomas J Hudzik
Brain, Behavior, and Immunity|August 21, 2012
Repeated stressor exposure regionally enhances beta-adrenergic receptor-mediated brain IL-1β productionVeronica M Porterfield, Kristin M Gabella, Mark A Simmons, et al.
Pharmacology Research & Perspectives|October 10, 2022
American Society for Pharmacology and Experimental Therapeutics Division for Pharmacology Education at EB2022-Meeting reportJoe B Blumer, Marieke Kruidering, Katharina Brandl, et al.
European Journal of Pharmacology|July 19, 2008
The role of the N-terminal and mid-region residues of substance P in regulating functional selectivity at the tachykinin NK1 receptorShane A Perrine, Debbie J Beard, John K Young, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|June 5, 2012
The adenosine 2A receptor agonist GW328267C improves lung function after acute lung injury in ratsHans G Folkesson, Stephanie R Kuzenko, David A Lipson, et al.
Pageof 2